ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 287459 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 287459; 2) Community: the network communities that were significantly associated with the response to NSC 287459; 3) Molecule: the relationships between components within communities and NSC 287459; 4) MDR: the compounds that were significantly associated with the NSC 287459.

NSC Compound Enrichment Correlation
NSC 638436 Null 0.000489907453833643 0.26864654
NSC 302325 2,4-Pyrimidinediamine, 5-(4-chloro-3-nitrophenyl)-6-ethyl- 0.000588249147782811 0.54893165
NSC 690042 6H-Pyrido[2,3,4-kl]acridin-6-one, 4-methoxy- 0.000588249147782811 0.26168071
NSC 697685 Null 0.000588249147782811 0.55844423
NSC 740613 Imidazole-5-one deri 0.000588249147782811 0.11759833
NSC 634794 Null 0.000614175706312789 0.11607172
NSC 654509 Pirarubicin HCl 0.000614175706312789 0.53850791
NSC 740 Methotrexate 0.000614175706312789 0.59901069
NSC 627988 Null 0.00101750714202618 0.27184059
NSC 734799 6-(3-Bromopropyl)-9-fluoro-5,6-dihydro-3-nitro-5,11-dioxo-11 H-indeno[1,2-c]isoquinoline 0.00101750714202618 0.49414263
Total:93  Current:2    [First] [Prev] [Next] [Last]